Can neupogen be given as an iv infusion?

Can Neupogen Be Given as an IV Infusion?

Yes, Neupogen (filgrastim) can be administered as an intravenous (IV) infusion, typically over 15 to 30 minutes for certain indications like chemotherapy-induced neutropenia.[1]

Standard Administration Methods

Neupogen is approved for subcutaneous injection or IV infusion via a short infusion (15-30 minutes) or continuous infusion (up to 24 hours). Subcutaneous is most common for outpatient use, while IV suits hospital settings.[1][2]

When Is IV Infusion Used?

IV infusion is recommended post-myeloablative chemotherapy or for bone marrow transplant patients needing rapid neutrophil recovery. Continuous IV over 24 hours may apply in specific transplant protocols.[1]

Dosage for IV Infusion

For adults post-chemotherapy: 5 mcg/kg/day as a 15-30 minute IV infusion or continuous over 24 hours, adjusted by neutrophil count. Pediatric doses are weight-based similarly.[1]

Differences from Subcutaneous Injection

IV achieves faster peak levels but requires venous access. Subcutaneous is self-administrable at home with slower absorption. Both routes are equally effective for most uses.[2]

Safety and Precautions for IV Use

Dilute in 5% Dextrose only; avoid saline to prevent aggregation. Monitor for infusion reactions like fever or rash. Not for intramuscular use.[1]

[1]: Neupogen Prescribing Information (FDA)
[2]: Drugs.com - Neupogen Administration